LncRNA NEAT1 promotes gastric cancer progression via miR-1294/AKT1 axis

被引:17
|
作者
Wu, Dianchao [1 ]
Li, Hui [1 ]
Wang, Junfeng [2 ]
Li, Hua [1 ]
Xiao, Qihai [1 ]
Zhao, Xiaofeng [1 ]
Huo, Zhibin [1 ]
机构
[1] Xingtai Peoples Hosp, Dept Surg Oncol, 16 Hongxing St, Xingtai 054031, Hebei, Peoples R China
[2] Tianjin Med Univ Canc Inst & Hosp, Dept Colorectal Surg, Tianjin, Peoples R China
来源
OPEN MEDICINE | 2020年 / 15卷 / 01期
关键词
NEAT1; gastric cancer; miR-1294; AKT1; PI3K/AKT/mTOR pathway; LONG NONCODING RNA; MIGRATION; INVASION; PROLIFERATION; EXPRESSION; GROWTH; CELLS;
D O I
10.1515/med-2020-0218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Long non-coding RNAs (lncRNAs) were reported to promote the development of gastric cancer (GC). Nuclear-enriched abundant transcript 1 (NEAT1) played a great role in diverse cancers, but the mechanism of NEAT1 in GC remains indistinct. NEAT1 and AKT1 were distinctly up-regulated and miR-1294 was down-regulated in GC tissues and cells. Cell proliferation and metastasis were refrained but apoptosis was promoted in GC cells after knockdown of NEAT1. NEAT1 negatively regulated miR-1294 expression, and the miR-1294 inhibitor reverted the si-NEAT1-induced effect on GC cells. NEAT1 modulated AKT1 expression through miR-1294, and the si-NEAT1-induced effect was relieved by AKT1. NEAT1 affected phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway via regulating miR-1294 and AKT1. NEAT1 could modulate cell proliferation, apoptosis, and metastasis in GC cells by regulating the PI3K/AKT/mTOR signaling pathway via the miR-1294/ AKT1 axis, showing the great potential for NEAT1 as a valid biomarker in the progression and treatment of GC.
引用
收藏
页码:1028 / 1038
页数:11
相关论文
共 50 条
  • [21] LncRNA NEAT1 Promotes Inflammatory Response in Sepsis via the miR-31-5p/POU2F1 Axis
    Yang, Yang
    Xue, Jianhua
    Qin, Lili
    Zhang, Jiaxuan
    Liu, Jiajia
    Yu, Junbo
    INFLAMMATION, 2021, 44 (04) : 1518 - 1528
  • [22] LncRNA NEAT1 Enhances Glioma Progression via Regulating the miR-128-3p/ITGA5 Axis
    Chen, Jiakai
    Wang, Handong
    Wang, Junjun
    Niu, Wenhao
    Deng, Chulei
    Zhou, Mengliang
    MOLECULAR NEUROBIOLOGY, 2021, 58 (10) : 5163 - 5177
  • [23] LncRNA NEAT1 Enhances Glioma Progression via Regulating the miR-128-3p/ITGA5 Axis
    Jiakai Chen
    Handong Wang
    Junjun Wang
    Wenhao Niu
    Chulei Deng
    Mengliang Zhou
    Molecular Neurobiology, 2021, 58 : 5163 - 5177
  • [24] LncRNA INHBA-AS1 promotes colorectal cancer cell proliferation by sponging miR-422a to increase AKT1 axis
    Lin, H.
    Hong, Y. -G.
    Zhou, J. -D.
    Gao, X. -H.
    Yuan, P. -H.
    Xin, C.
    Huang, Z. -P.
    Zhang, W.
    Hao, L. -Q.
    Hou, K. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (19) : 9940 - 9948
  • [25] LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1
    Jingshan Liang
    Changtao Liu
    Dezhi Xu
    Kang Xie
    Aimin Li
    Journal of Translational Medicine, 20
  • [26] lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT
    Zhang, M.
    Wu, W. -B.
    Wang, Z. -W.
    Wang, X. -H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (05) : 1020 - 1026
  • [27] MiR-1294 inhibits the progression of breast cancer via regulating ERK signaling
    Chen, Kejie
    Xiao, Xiapeng
    Xu, Zhiping
    BULLETIN DU CANCER, 2022, 109 (10) : 999 - 1006
  • [28] The lncRNA Neat1 promotes activation of inflammasomes in macrophages
    Pengfei Zhang
    Limian Cao
    Rongbin Zhou
    Xiaolu Yang
    Mian Wu
    Nature Communications, 10
  • [29] LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p
    Yu, Hong-Mei
    Wang, Chen
    Yuan, Zhen
    Chen, Guang-Liang
    Ye, Tao
    Yang, Bi-Wei
    CELL PROLIFERATION, 2019, 52 (01)
  • [30] NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression
    Zhao, Dahua
    Zhang, Ying
    Wang, Nana
    Yu, Ning
    CANCER BIOMARKERS, 2017, 20 (03) : 247 - 254